BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Visa
V
|
+$333M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$265M |
| 3 |
Motorola Solutions
MSI
|
+$222M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$220M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
+$193M |
Top Sells
| 1 |
Apple
AAPL
|
+$251M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$196M |
| 3 |
Alibaba
BABA
|
+$193M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$130M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| 1 | Technology | 14.35% |
| 2 | Financials | 12.02% |
| 3 | Consumer Discretionary | 9.44% |
| 4 | Healthcare | 8.58% |
| 5 | Industrials | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3201
MainStreet Bancshares
MNSB
$168M
| $18.9K | ﹤0.01% |
897
+555
| +162% | +$11.7K |
|
3202
Kiniksa Pharmaceuticals
KNSA
$2.75B
| $18.9K | ﹤0.01% |
2,216
+679
| +44% | +$5.78K |
|
3203
Zynex
ZYXI
$46.4M
| $18.8K | ﹤0.01% |
2,178
+2,134
| +4,850% | +$18.5K |
|
|
MSON
3204
DELISTED
Misonix Inc
MSON
| $18.8K | ﹤0.01% |
935
+916
| +4,821% | +$18.4K |
|
3205
Vanguard Information Technology ETF
VGT
$103B
| $18.8K | ﹤0.01% |
87
| – | – |
|
|
DLA
3206
DELISTED
Delta Apparel Inc.
DLA
| $18.6K | ﹤0.01% |
784
+475
| +154% | +$11.3K |
|
|
MMAC
3207
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
| $18.6K | ﹤0.01% |
620
+383
| +162% | +$11.5K |
|
|
ADMS
3208
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $18.5K | ﹤0.01% |
3,611
+1,100
| +44% | +$5.63K |
|
3209
Angi Inc
ANGI
$783M
| $18.5K | ﹤0.01% |
261
+59
| +29% | +$4.17K |
|
3210
Coastal Financial
CCB
$1.68B
| $18.4K | ﹤0.01% |
1,221
+261
| +27% | +$3.94K |
|
3211
Biglari Holdings Class B
BH
$985M
| $18.4K | ﹤0.01% |
169
+46
| +37% | +$5.01K |
|
3212
Franco-Nevada
FNV
$39.2B
| $18.2K | ﹤0.01% |
200
| – | – |
|
3213
LSB Industries
LXU
$575M
| $18.2K | ﹤0.01% |
4,564
-362
| -7% | -$1.44K |
|
3214
Energous
WATT
$11.2M
| $18.2K | ﹤0.01% |
9
+2
| +29% | +$4.04K |
|
|
PYX
3215
DELISTED
Pyxus International, Inc.
PYX
| $18.1K | ﹤0.01% |
1,385
-501
| -27% | -$6.55K |
|
3216
Aldeyra Therapeutics
ALDX
$331M
| $18.1K | ﹤0.01% |
3,434
+856
| +33% | +$4.51K |
|
3217
Ocular Therapeutix
OCUL
$2.24B
| $18K | ﹤0.01% |
5,935
+1,862
| +46% | +$5.66K |
|
|
CMRX
3218
DELISTED
Chimerix, Inc.
CMRX
| $18K | ﹤0.01% |
7,669
+137
| +2% | +$322 |
|
|
MFNC
3219
DELISTED
Mackinac Financial Corporation
MFNC
| $18K | ﹤0.01% |
1,165
+721
| +162% | +$11.1K |
|
3220
Kinetik
KNTK
$2.66B
| $18K | ﹤0.01% |
636
+623
| +4,792% | +$17.6K |
|
3221
Suburban Propane Partners
SPH
$1.22B
| $18K | ﹤0.01% |
760
-470
| -38% | -$11.1K |
|
|
TYME
3222
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $17.9K | ﹤0.01% |
15,036
+2,827
| +23% | +$3.36K |
|
3223
Lennar Class B
LEN.B
$34.7B
| $17.9K | ﹤0.01% |
424
+143
| +51% | +$6.03K |
|
|
GBL
3224
DELISTED
GAMCO Investors, Inc.
GBL
| $17.9K | ﹤0.01% |
914
+256
| +39% | +$5.01K |
|
3225
Frontline
FRO
$5.2B
| $17.8K | ﹤0.01% |
1,951
-6,694
| -77% | -$60.9K |
|